Roche looking to sell or shut down California biologic drug plant – Reuters News Agency

[ad_1]

DealsHealth

Reuters has exclusively seen documents indicating Swiss drugmaker Roche Holding AG (ROG.S) plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029. 

Market Impact

Roche is under pressure to develop new treatments to offset the loss of billions in sales due to cheap biotech copies of its established cancer medicines Herceptin, Avastin and Rituxan.

Article Tags

Topics of Interest: DealsHealth

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Americas

Countries: SwitzerlandUnited States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

[ad_2]

Source link

Leave a Comment